John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$254M |
| 2 |
Bank of America
BAC
|
+$228M |
| 3 |
KLA
KLAC
|
+$205M |
| 4 |
TSMC
TSM
|
+$191M |
| 5 |
CVS Health
CVS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Meta Platforms (Facebook)
META
|
+$254M |
| 3 |
Goldman Sachs
GS
|
+$237M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
PayPal
PYPL
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.63% |
| 2 | Healthcare | 13.66% |
| 3 | Financials | 12.92% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Globalstar
GSAT
$10.7B
| $67.7K | ﹤0.01% |
+3,641
| New | +$67.4K |
|
2902
PDS Biotechnology
PDSB
$12M
| $67.2K | ﹤0.01% |
17,600
| – | – |
|
2903
Hycroft Mining Holding Corp
HYMC
$2.44B
| $67.1K | ﹤0.01% |
26,821
+4,648
| +21% | +$11.2K |
|
2904
Scilex Holding
SCLX
$40.4M
| $67K | ﹤0.01% |
2,070
-50
| -2% | -$2.4K |
|
2905
Intellicheck
IDN
$59M
| $66K | ﹤0.01% |
30,428
-19,607
| -39% | -$51.4K |
|
2906
INmune Bio
INMB
$66.1M
| $65.7K | ﹤0.01% |
+12,184
| New | +$86.6K |
|
2907
Rimini Street
RMNI
$485M
| $64.6K | ﹤0.01% |
34,910
-56,518
| -62% | -$125K |
|
2908
OmniAb
OABI
$635M
| $64.3K | ﹤0.01% |
+15,201
| New | +$65.7K |
|
2909
VirTra
VTSI
$33.5M
| $62.9K | ﹤0.01% |
10,118
-11,094
| -52% | -$80.7K |
|
2910
Sentage Holdings
SNTG
$4.71M
| $62.6K | ﹤0.01% |
+26,868
| New | +$59.9K |
|
2911
Dakota Gold
DC
$827M
| $61.2K | ﹤0.01% |
25,946
+10,306
| +66% | +$23.6K |
|
|
SYRS
2912
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $61.2K | ﹤0.01% |
28,475
-11,791
| -29% | -$42.4K |
|
|
AEVA
2913
Aeva Technologies
AEVA
$1.16B
| $59.8K | ﹤0.01% |
18,181
-2,000
| -10% | -$5.99K |
|
|
BINI
2914
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
|
UNIT
2915
PUT
Uniti Group
UNIT
$2.39B
| $56.4K | ﹤0.01% |
10,000
| – | – |
|
2916
Real Brokerage
REAX
$490M
| $56.1K | ﹤0.01% |
10,100
+100
| +1% | +$568 |
|
2917
Rackspace Technology
RXT
$813M
| $55.6K | ﹤0.01% |
22,683
-22,612
| -50% | -$54.6K |
|
|
HLVX
2918
DELISTED
HilleVax
HLVX
| $55.4K | ﹤0.01% |
31,496
-44,912
| -59% | -$115K |
|
|
LICY
2919
DELISTED
Li-Cycle Holdings Corp.
LICY
| $54.8K | ﹤0.01% |
25,004
+9,226
| +58% | +$25.5K |
|
2920
GeoVax Labs
GOVX
$3.61M
| $54.4K | ﹤0.01% |
+904
| New | +$76K |
|
|
ADAP
2921
DELISTED
Adaptimmune Therapeutics
ADAP
| $54.4K | ﹤0.01% |
+57,201
| New | +$64.9K |
|
2922
Vivos Therapeutics
VVOS
$5.79M
| $53.5K | ﹤0.01% |
+20,482
| New | +$53.6K |
|
2923
Southland Holdings Warrants
SLND.WS
| $52.8K | ﹤0.01% |
142,124
| – | – |
|
2924
Definitive Healthcare
DH
$79.6M
| $51.4K | ﹤0.01% |
+11,500
| New | +$54K |
|
|
MYSE
2925
Myseum.AI Inc
MYSE
$14.1M
| $51K | ﹤0.01% |
+39,239
| New | +$53.1K |
|
Similar funds
John Overdeck's Q3 2024 Portfolio in Review
As of Q3 2024, John Overdeck held 3,433 positions worth $45.6B, up 3.9% from $43.9B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.
John Overdeck withdrew a net $1.83B in Q3 2024, closing 348 positions and reducing 1,306 holdings. Its most notable exit was Intel, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Bank of America worth $226M.
- John Overdeck's largest Q3 2024 buy was Bank of America: 5,683,991 shares worth $226M.
- John Overdeck added most to Alphabet (Google) Class A in Q3 2024, an estimated $254M increase.
- John Overdeck's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.06B.
- John Overdeck fully exited Intel in Q3 2024, selling an estimated $161M.
- John Overdeck's ten largest holdings make up 6.6% of its $45.6B portfolio in Q3 2024.
- John Overdeck opened 444 new positions and closed 348 in Q3 2024.
- John Overdeck's portfolio value rose 3.9% quarter-over-quarter to $45.6B.
Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.